Non-paroxysmal junctional tachycardia (NPJT) is a supraventricular arrhythmia characterized by an accelerated rhythm generated at the level of the atrioventricular (AV) junction, with a typical rate ranging between 70 and 130 bpm. Unlike reentrant tachycardias, NPJT is not determined by a reentry circuit, but by an alteration of the automaticity of junctional cells or by abnormal electrical activity, often secondary to an underlying condition.
NPJT can occur in various clinical contexts, including digitalis intoxication, myocardial ischemia, electrolyte imbalances, and cardiac surgery. It is more frequent in pediatric patients with operated congenital heart disease, but can also be observed in adults with cardiac or metabolic diseases. Although often benign and transient, in some cases it may compromise hemodynamics, especially in patients with pre-existing ventricular dysfunction.
The diagnosis is based on the electrocardiogram (ECG), which shows a regular rhythm with a narrow QRS and retrograde or absent P waves. Treatment is mainly focused on correcting the underlying cause, while the use of antiarrhythmic drugs or other therapeutic strategies is reserved for persistent symptomatic cases.
NPJT results from abnormal electrical activity at the AV junction. Unlike reentrant tachycardias, in which the impulse is perpetuated by a closed circuit, in NPJT the AV node takes on the role of an ectopic pacemaker, generating impulses independently of atrial activity.
The main pathogenetic mechanisms include:
NPJT is frequently a secondary tachycardia, induced by an underlying pathological condition. The main causes include:
From a pathophysiological standpoint, NPJT is characterized by abnormal impulse generation at the AV junction, with a regular rhythm and a frequency rarely exceeding 130 bpm. This accelerated rhythm results in simultaneous activation of atria and ventricles, leading to atrioventricular dyssynchrony.
In patients with reduced cardiac reserve, the loss of synchronous atrial contraction may significantly decrease cardiac output, causing hypotension and symptoms of low systemic perfusion. In patients with digitalis intoxication, NPJT may be associated with AV block of varying degree, resulting in impaired conduction and more pronounced symptoms.
Non-paroxysmal junctional tachycardia (NPJT) is typically a secondary arrhythmia, arising from pathological conditions that alter the normal function of the atrioventricular junction. It is not a primary arrhythmia, but rather a manifestation associated with predisposing factors that promote abnormal activation of the AV node.
The main risk factor for the development of NPJT is digitalis intoxication, a condition in which excess digitalis alters intracellular calcium metabolism and predisposes to triggered activity at the AV junction. Other contributing factors include myocardial ischemia, electrolyte imbalances, cardiac surgery, and inflammatory processes. For example, inferior myocardial infarction may impair the normal autonomic control of the AV junction, while electrolyte imbalances may alter the stability of junctional pacemaker cells.
In pediatric patients, NPJT is more frequently observed following cardiac surgery for congenital heart disease or as a consequence of viral myocarditis. The presence of an immature autonomic nervous system may favor transient episodes of NPJT in neonates.
Prevention of NPJT is based on the management of predisposing factors. In at-risk patients, it is essential to avoid digitalis overdose, correct electrolyte imbalances, and carefully monitor patients undergoing cardiac surgery. In particular, in subjects with myocardial ischemia, control of oxygenation and autonomic balance may reduce the risk of tachycardia onset.
NPJT may present as asymptomatic or with mild symptoms, especially in patients without hemodynamic compromise. Many subjects discover the tachycardia incidentally, during an ECG performed for other reasons. In symptomatic cases, the patient generally reports regular palpitations, often accompanied by fatigue and sense of weakness.
In patients with pre-existing ventricular dysfunction, tachycardia may reduce diastolic filling and lead to decreased cardiac output, resulting in dyspnea and exercise intolerance. In more severe cases, especially in patients with acute myocardial ischemia, hypotension with symptoms of hypoperfusion, such as dizziness and near-syncope, may occur. NPJT induced by digitalis intoxication is often associated with more complex symptoms, which may include visual disturbances, nausea, and mental confusion.
During an NPJT episode, the main finding is regular tachycardia, with rates generally between 70 and 130 bpm. The pulse is regular and easily palpable, without the irregularity typical of atrial fibrillation or other atrial tachycardias. Blood pressure is usually normal, but in individuals with compromised ventricular function hypotension may occur.
On cardiac auscultation, heart sounds are rhythmic, without evident anomalies. In patients with sustained NPJT, the loss of atrioventricular synchrony may lead to reduced ventricular filling, with consequent changes in pulmonary filling in predisposed individuals.
In patients with digitalis intoxication, the physical exam may show associated signs such as neurological disturbances, nausea, and visual disorders. In pediatric patients with postoperative NPJT, tachycardia is often transient and self-limiting, tending to resolve spontaneously over time.
The diagnosis of non-paroxysmal junctional tachycardia (NPJT) is based on clinical identification and electrocardiographic confirmation of the arrhythmia. Diagnostic suspicion arises in patients with a regular tachycardia with non-abrupt onset, especially if associated with predisposing factors such as digitalis intoxication, myocardial ischemia, or electrolyte imbalances.
NPJT may be asymptomatic or present with mild symptoms such as palpitations and fatigue, while in patients with heart disease it may cause hemodynamic instability.
During an episode, physical examination reveals a regular tachycardic rhythm, with rates between 70 and 130 bpm. Blood pressure is generally preserved, but in subjects with pre-existing ventricular dysfunction, hypotension may occur. Cardiac auscultation does not reveal pathological murmurs, but in patients with sustained NPJT, reduced ventricular filling may be detected, with possible pulmonary congestion in predisposed subjects.
The electrocardiogram (ECG) is the main diagnostic tool for NPJT and allows differentiation from other supraventricular tachycardias.
Distinctive features include:
The presence of retrograde P waves with a regular rhythm distinguishes NPJT from atrial tachycardias, while the lack of sudden onset helps differentiate it from AV reentrant tachycardia (AVNRT or AVRT). In patients with digitalis intoxication, the ECG may show associated changes such as ST segment depression and PR interval prolongation.
In patients with intermittent episodes not documentable with standard ECG, prolonged monitoring may be useful to confirm the diagnosis. Depending on the frequency of episodes, the following may be used:
In cases where the diagnosis is unclear, pharmacological tests or physiological maneuvers may be performed to assess the nature of the tachycardia. Adenosine administration can help distinguish NPJT from reentrant tachycardias: in NPJT, adenosine does not interrupt the arrhythmia but may highlight AV dissociation. In contrast, in reentrant tachycardias, transient AV node block leads to arrhythmia termination.
Vagal maneuvers, such as the Valsalva maneuver or carotid sinus massage, can slow AV conduction, helping to assess the relationship between atrial and ventricular activity.
In patients with persistent episodes and in cases where NPJT is difficult to distinguish from other supraventricular arrhythmias, electrophysiological study (EPS) can provide detailed information on AV conduction. This test allows:
The electrophysiological study is particularly useful in patients with postoperative NPJT, where tachycardia may be associated with structural changes at the AV junction.
Management of non-paroxysmal junctional tachycardia (NPJT) focuses on the identification and treatment of the underlying cause. As it is often a secondary tachycardia, resolution occurs in most cases by correcting the triggering factor. Unlike reentrant tachycardias, NPJT rarely requires specific antiarrhythmic treatments, while it is crucial to monitor the patient for possible hemodynamic complications.
In patients with symptomatic NPJT, the first step is to assess hemodynamic stability. If the patient is hemodynamically stable, immediate interruption of tachycardia is not required, but the triggering factor must be identified. In cases of NPJT secondary to digitalis intoxication, digitalis withdrawal and restoration of electrolyte balance are priorities. In patients with myocardial ischemia, treatment of the ischemic event may lead to resolution of the tachycardia.
Unlike reentrant tachycardias, adenosine, vagal maneuvers, and electrical cardioversion are not effective in NPJT and should not be used to terminate the arrhythmia.
If NPJT is persistent and symptomatic, beta-blockers or non-dihydropyridine calcium channel blockers can be used to reduce the automatic activity of the AV node and control heart rate. However, these drugs should be used with caution in patients with heart failure or pre-existing bradycardia.
Transcatheter ablation is generally not indicated for NPJT, as there is no reentrant circuit to eliminate. However, in rare cases where tachycardia is highly symptomatic and resistant to pharmacological treatment, targeted ablation of hyperactive junctional cells may be considered, although with a risk of permanent AV block.
The prognosis of NPJT is generally favorable, with spontaneous resolution in most cases after correction of the underlying cause. In patients with NPJT associated with digitalis intoxication, recovery occurs with discontinuation of the drug and monitoring of serum digitalis levels.
In subjects with postoperative NPJT, tachycardia may persist for weeks or months before resolving spontaneously. In rare cases, in patients with structural AV node damage, NPJT may become chronic and require long-term pharmacological control.
Although benign in most cases, NPJT can lead to some complications, especially in patients with underlying heart disease.
In patients with sustained NPJT, elevated heart rate for prolonged periods can cause ventricular remodeling with development of left ventricular dysfunction. This condition is generally reversible with control of tachycardia.
Loss of atrioventricular synchrony can reduce ventricular filling, resulting in hypotension and symptoms of low systemic perfusion in predisposed subjects.
In some patients with sinus node dysfunction, NPJT may represent a sign of sick sinus syndrome, with alternation between tachycardic and bradycardic episodes.
In rare cases where NPJT is refractory and requires AV junction ablation, the main risk is the need for a permanent pacemaker to maintain adequate cardiac function.